Board Meetings for TORNTPHARM
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| TORNTPHARM | Torrent Pharmaceuticals Limited | 30 Jan 2019 | Financial Results/Dividend/Fund Raising | To consider and approve the financial results for the period ended December 31, 2018, dividend and Fund Raising | |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 03 Nov 2018 | Financial Results | To consider and approve the financial results for the period ended September 30, 2018 | |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 02 Aug 2018 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 | |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 30 May 2018 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2018 and dividend | |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 08 Feb 2018 | Results/Dividend | inter alia to consider and approve the Financial Results on Standalone and Consolidated basis of the Company for the quarter and nine months ended on December 31, 2017. 2) In the above meeting, the Board would also consider payment of Interim Dividend for the year 2017-18. 3) As per Regulation 42 of the Listing Regulations, the Company has fixed February 19, 2017,as the Record date for the purpose of payment of said Interim dividend, if declared by the board at their aforesaid meeting, payable to those shareholders whose name appears on the Register of Members or on records of National Securities Depositories Limited or Central Depositories Services ( India) Limited as beneficial owners as on said record date. | |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 25 Jan 2018 | Raising of Funds | to consider inter-alia the following: 1) Issue of Equity shares including Convertible Bonds/Debentures through Qualified Institutional Placement ( QIP) and /or Depository Receipts or any other modes. 2) Issue of Unsecured/Secured Redeemable Non-Convertible Debentures/Bonds by way of private placement. | |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 03 Nov 2017 | Results | inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results ( with Limited review) on Consolidated basis of the Company for the quarter and half year ended on September 30, 2017. | |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 31 Jul 2017 | Results | inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results ( with limited review) on Consolidated basis of the Company for the quarter ended on June 30, 2017. | |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 26 May 2017 | Results/Dividend | Inter alia to consider and approve the Audited Financial Results for the year ended on March 31, 2017 and to consider for recommendation of final dividend for the year ended March 31, 2017. The Board would also consider the proposal for taking the enabling resolutions for raising of funds by way of Issue of Unsecured / Secured Redeemable Non-Convertible Debentures/ Bonds by way of Private Placement. If approved by the Board of Directors, the said item will be placed Shareholders' approval in the ensuing Annual General Meeting. | |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 03 Feb 2017 | Results/Dividend | Inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on December 31, 2016. Further the Board would also consider payment of Interim Dividend for the year 2016-17. | |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 26 Oct 2016 | Results | To consider inter-alia the Audited Financial Results on Standalone basis and Unaudited Financial Result (with limited review) on Consolidated basis of the Company for the quarter and half year ended on September 30, 2016. | |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 27 Jul 2016 | Results | To consider inter-alia the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on June 30, 2016. Further Company would like to inform that, as per the provisions of the Code of Conduct to Regulate, Monitor and Report Trading by Insiders of the Company, the trading window will remain closed between July 13, 2016 to July 29, 2016. | |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 23 May 2016 | Results | to consider inter-alia the Audited Financial Results for the year ended on March 31, 2016. | |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 23 Mar 2016 | Issue of Securities | To consider inter-alia the proposal for raising of funds by way of: a) Issue of Equity shares including Convertible Bonds/Debentures through Qualified Institutional Placements (QIP) and/ or Depository Receipts and I or any other modes. b) Issue of Unsecured I Secured Redeemable Non-Convertible Debentures/ Bonds by way of Private Placement. | |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 09 Mar 2016 | Dividend | To consider inter-alia the proposal for declaration of Second Interim Dividend, if any, for the year 2015-16. |